Promising New Treatment for Prostate Cancer Also Demonstrates Encouraging Results Against Triple Negative Breast Cancer

Efficacy Preclinical Studies Conducted by UTRF, UTHSC, and Veru Inc.’s University-Industry Partnership Memphis, Tennessee: A research collaboration between the University of Tennessee Health Science Center (UTHSC), the University of Tennessee Research Foundation (UTRF), and biopharmaceutical company Veru Inc. has resulted in a promising next generation oral cancer therapy, VERU-111, which has the potential to treat… Read More

2020 UTRF Technology Maturation Grant – Call for Submissions

The University of Tennessee Research Foundation (UTRF) is announcing a call for submissions for the twelfth annual UTRF Technology Maturation Grant program. The annual maturation program aims to assist researches in advancing new technologies on the path to market by awarding up to $15,000 in direct costs to the highest ranking proposals. The program is… Read More

Electro-Active Technologies licenses biorefinery innovations jointly patented by ORNL and UTRF

Electro-Active Technologies, Inc., of Knoxville, Tenn., has exclusively licensed two biorefinery technologies invented and patented by the startup’s co-founders while working at the Department of Energy’s Oak Ridge National Laboratory. The technologies work as a system that converts organic waste into renewable hydrogen gas for use as a biofuel. The system combines biology and electrochemistry… Read More